The effect of different intervention programs on treatment adherence of HIV-infected children, a retrospective study

Atie van der Plas1, Henriette Scherpbier, Taco Kuijpers

  • 1Academic Medical Centre, Department of Paediatric Infectious Diseases, Emma Children's Hospital, Amsterdam, The Netherlands. a.vanderplas@amc.uva.nl

AIDS Care
|December 13, 2012
PubMed

Insights

Treatment adherence programs significantly improve combination anti-retroviral therapy (cART) adherence in children with HIV. A novel reward-based program, combined with social support, shows promise in reducing healthcare needs and improving outcomes.

Area of Science:

  • Pediatric infectious diseases
  • Public health
  • Behavioral science

Background:

  • Long-term adherence to combination anti-retroviral therapy (cART) is a significant challenge for children with HIV.
  • Effective adherence strategies are crucial for managing pediatric HIV and preventing treatment failures.

Purpose of the Study:

  • To evaluate the impact of two distinct treatment adherence programs on cART adherence and supportive care needs in HIV-infected children.
  • To compare the effectiveness of a punitive approach versus a reward-based approach to improving medication adherence.

Main Methods:

  • Retrospective analysis of 31 HIV-infected children (ages 3-18) over a 6-year period.
  • Assessment of cART failures and supportive care measures (hospitalizations, foster care) at baseline and after two intervention programs.
  • Intervention 1: Negative reinforcement for treatment failure; Intervention 2: Positive reinforcement for optimal medication intake.

Main Results:

  • cART failures decreased from 29% at baseline to 6% after the first program and remained low at 10% during the second program.
  • The reward-based program significantly reduced the need for hospitalizations and foster home placements.
  • Both adherence programs demonstrated effectiveness in improving cART adherence.

Conclusions:

  • Treatment adherence programs are effective in enhancing cART adherence among pediatric HIV patients.
  • A novel reward-based intervention, integrated with social support, offers a promising positive reinforcement strategy.
  • This approach can potentially decrease the reliance on extensive supportive care measures in managing pediatric HIV.

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...